International
The Morning Science

What science found today

‹
 

Research

Silencing a liver gene may prevent brain damage from rare metabolic disease

Medical Xpress ·

Silencing a liver gene may prevent brain damage from rare metabolic disease

The Brief

  • A Duke University School of Medicine study reports the first preclinical success of a liver-targeting treatment for glutaric aciduria type I (GA1).
  • The approach silences a liver gene as a way to protect the brain from damage caused by GA1, a rare metabolic disease.
  • The findings are preclinical, so they have not yet been tested in human patients.

Why it matters

It suggests a new strategy for a rare brain-damaging metabolic disorder, showing that targeting the liver may affect neurological outcomes.

Who’s affected

  • researchers and clinicians working on rare metabolic diseases
  • families affected by glutaric aciduria type I

What if the path to treating a rare condition that harms the brain goes through the liver? A new study by Duke University School of Medicine researchers is the first to show preclinical success of a liver-targeting treatment of glutaric aciduria type I (GA1).

Timeline

  1. Medical Xpress reports on the Duke University study showing preclinical success of the liver-targeting treatment

  2. Medical Xpress - latest medical and health news stories

    Silencing a liver gene may prevent brain damage from rare metabolic disease

How do you feel about this?

0 Comments

    Silencing a liver gene may prevent brain damage from rare metabolic disease – The Morning Science